Tickertape - Financial freedom begins here
- NIFTY 5024,092.700.81% 194.75
- SENSEX77,303.630.83% 639.42
- MARKET MOOD14:20
Greed
Market and sectors
See All| NIFTY 100 Largecap | 25,068.900.97% | |
| NIFTY 100 Midcap | 60,294.551.55% | |
| NIFTY 100 Smallcap | 17,911.951.96% |
| NIFTY Bank | 56,296.350.37% | |
| NIFTY IT | 29,199.702.35% | |
| NIFTY Pharma | 23,147.752.51% |
| NIFTY 100 Largecap | 25,068.900.97% | |
| NIFTY 100 Midcap | 60,294.551.55% | |
| NIFTY 100 Smallcap | 17,911.951.96% |
| NIFTY Bank | 56,296.350.37% | |
| NIFTY IT | 29,199.702.35% | |
| NIFTY Pharma | 23,147.752.51% |
Today's stocks
| STOCKSPRICECHANGE | |
Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,733.506.98% |
Hindustan Zinc LtdHINDZINC | ₹628.006.71% |
₹518.855.79% | |
Tata Power Company LtdTATAPOWER | ₹453.204.18% |
₹348.583.32% |
Mutual funds and ETFs
| FUNDSRETURNS | |
Equity • Growth | |
5.95% Equity • Growth | |
4.84% Equity • Growth | |
Equity • Growth | |
Equity • Growth |
Curated screens and deals
Market and sectors
See All| NIFTY 100 Largecap | 25,068.900.97% | |
| NIFTY 100 Midcap | 60,294.551.55% | |
| NIFTY 100 Smallcap | 17,911.951.96% |
| NIFTY Bank | 56,296.350.37% | |
| NIFTY IT | 29,199.702.35% | |
| NIFTY Pharma | 23,147.752.51% |
| NIFTY 100 Largecap | 25,068.900.97% | |
| NIFTY 100 Midcap | 60,294.551.55% | |
| NIFTY 100 Smallcap | 17,911.951.96% |
| NIFTY Bank | 56,296.350.37% | |
| NIFTY IT | 29,199.702.35% | |
| NIFTY Pharma | 23,147.752.51% |
Today's stocks
| STOCKSPRICECHANGE | |
Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,733.506.98% |
Hindustan Zinc LtdHINDZINC | ₹628.006.71% |
₹518.855.79% | |
Tata Power Company LtdTATAPOWER | ₹453.204.18% |
₹348.583.32% |
Curated screens and deals
Supreme Industries announced that the 84th Annual General Meeting(AGM) of the company will be held on 3 July 2026.
Kirloskar Pneumatic Company announced that the 51st Annual General Meeting(AGM) of the company will be held on 21 July 2026.
The board of Global Health at its meeting held today i.e. 27 April 2026, has inter alia, approved execution of a Business Transfer Agreement (BTA) for a 79 bedded Cancer Care Hospital in Indore, assignment of lease deed as part of the transaction and execution of fresh lease for an additional 1,700 sqft of the space within the facility. The target hospital is in close proximity to Company's existing facility in Indore. The hospital is strategically located just 500 meters from Medanta Indore existing facility and will enable seamless integration and operational synergies. The target hospital has been purpose-built with a primary focus on cancer care. The transaction will allow Medanta to further strengthen its presence in the region, enhance its portfolio of tertiary and quaternary care services, and fill the existing specialty gap in oncology.
Mutual funds and ETFs
| FUNDSRETURNS | |
Equity • Growth | |
5.95% Equity • Growth | |
4.84% Equity • Growth | |
Equity • Growth | |
Equity • Growth |
Money
Matters
- Assets tracked worth60,500 Cr
- Loved by60 L+ investors
- Downloads6.2M+
- Rated on Google Play4.2


_POZoAT-L2.png)
%20(1)_BKz_bMFSp.png)
